Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Osmotic Therapy (Mannitol or Hypertonic Saline)
Treatment for Intracerebral hemorrhage
Typical Dosage: Mannitol (0.25-1 g/kg IV), Hypertonic Saline (e.g., 3% NaCl 100-250ml IV bolus)
Effectiveness
85%
Safety Score
60%
Clinical Trials
40
Participants
6K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Dosage Range
Mannitol (0.25-1 g/kg IV), Hypertonic Saline (e.g., 3% NaCl 100-250ml IV bolus)
Time to Effect
Minutes
Treatment Duration
Hours to days
Evidence Quality
MODERATENumber Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
20(Treat 20 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$200
Side Effect Mgmt:$100
Total Annual:$800
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$10,000/QALY
QALYs Gained
1
Outcome-Based Costs
Cost per Responder
$1,000
Osmotic Therapy (Mannitol or Hypertonic Saline) Outcomes
for Intracerebral hemorrhage
Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+80%
Common Side Effects
Electrolyte imbalance (e.g., hypernatremia)
+15%
Renal dysfunction (with Mannitol)
+5%
Hypotension
+3%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov